CSF1R and neuroblastoma: Similarly, depletion of human monocytes and macrophages through CSF-1R inhibition using BLZ945, in combination with anti-CSF-1R treatment, enhanced chemotherapeutic efficacy in immunodeficient NOD/SCID mice with neuroblastoma xenografts, independently of T cell contribution [167].